Quang X. Pham - Jan 23, 2025 Form SCHEDULE 13D Schedule Report for Cadrenal Therapeutics, Inc. (CVKD)

Filing Manager: Pham Quang X
Reporting Manager: Quang X. Pham
Security: Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: CVKD
Shares outstanding: 1.78M shares
Disclosed Ownership: 421K shares
Ownership: 23.6%
Form type: SCHEDULE 13D
Date filed: 1/29/2025, 07:29 PM
Date of event: Jan 23, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Quang X. Pham	23.6%	421K	221K	200K	/s/ Quang X. Pham	Quang X. Pham	0001405290
The PVBQ Living Trust	11.2%	200K	0	200K	/s/ Quang X. Pham	Quang X. Pham, Trustee	0001947432